Search Results for ""

Prostate cancer is the most common cancer among those assigned male at birth, with one in eight diagnosed during their lifetime. But with five-year survival rates of 90%, it’s also one of the most successful cancers to treat, making survivorship care even more important.

Congratulations to ONS Director-at-Large Valerie Burger, RN, MA, MS, OCN®, CPN, whom the ONS Board of Directors selected as treasurer, and ONS Director-at-Large Darcy Burbage, DNP, RN, AOCN®, CBCN®, whom it selected as secretary, during its April 13, 2021, meeting.

Introducing palliative care from the moment of diagnosis is an essential component of comprehensive care, but it becomes even more critical when patients contract the COVID-19 coronavirus during treatment.  

My team’s current project to understand communication in ambulatory oncology settings stems from more than a decade of research, in which we have tried to uncover the factors that facilitate high-quality cancer care for patients and a satisfying practice environment for care teams.

During the last month of life, non-White patients are more likely to receive aggressive care with little to no focus on palliative or end-of-life (EOL) care for their ovarian cancer, researchers reported in Cancer.

As the number of cancer survivors continues to grow in the United States, so too does the need for cancer survivorship programs. Oncology advanced practice RNs (APRNs) are essential team members as institutions develop and deliver comprehensive and holistic programs to meet survivors’ needs.

“The Grief Crisis Is Coming.” So warned the headline of a New York Times editorial in which the author described the toll of losses from the pandemic on the individual level. She said that for each person who dies from COVID-19, nine loved ones have been left behind to grieve, according to the COVID-19 Bereavement Multiplier introduced by a professor at Pennsylvania State University. That number is conservative and does not consider the healthcare team that cared for those patients.

Nurses have an innate drive to improve healthcare delivery. When I was a unit director, I focused on nursing unit turnarounds to improve quality of care. I used mediation as the model for resolving long-time conflicts and provided training to effectively engage and communicate. I started my mediation practice in 2003 to help physicians, nurses, and administrators resolve the complex issues that get in the way of patient care and create stressful work environments.  

Lab-developed antibodies using a single-chain diabody format can target TP53 or RAS variants in solid tumors and T-cell receptor (TCR) variants in blood cancers, researchers reported in study findings published in Science, Science Immunology, and Science Translational Medicine, respectively.

Tepotinib (Tepmetko®) was granted accelerated approval in February 2021 for mesenchymalepithelial transition (MET)-altered metastatic non-small cell lung cancer (NSCLC) based on overall response rate and duration. The drug is still under long-term evaluation and healthcare providers should report all serious adverse events that may be associated to FDA’s MedWatch Reporting System.